1 study found for:    ((BAY86-9766 AND GIST) OR NCT01392521)
Show Display Options
Download search resultsDownload the search results for:
((BAY86-9766 AND GIST) OR NCT01392521) (1 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Protein Kinase) Inhibitor Refametinib (BAY86-9766) in Patients With Advanced Cancer
Condition: Neoplasms
Intervention: Drug: Copanlisib + Refametinib (BAY86-9766)

Indicates status has not been verified in more than two years